New wireless monitor aims to prevent dangerous low blood sugar in hospitalized veterans
NCT ID NCT03508934
First seen Jan 09, 2026 · Last updated Jun 19, 2026 · Updated 28 times
Summary
This study tests a wireless glucose monitoring system (Glucose Telemetry System) in 218 hospitalized veterans with type 2 diabetes who are at high risk for low blood sugar (hypoglycemia). The device sends blood sugar readings from the patient's bedside to a monitor at the nursing station, allowing staff to act quickly. The goal is to reduce hypoglycemia episodes, which can cause seizures, heart problems, or death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, 21201, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous glucose monitoring device (Glucose Telemetry System)
What this could lead to
If successful, this could provide a safer way to monitor blood sugar in hospitalized patients, reducing the risk of severe hypoglycemia and its complications.
What could go wrong
This is a relatively small, early-stage study focused on a specific population (veterans), so results may not apply to all patients. The device may not significantly reduce hypoglycemia compared to standard care.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.